Literature DB >> 24333758

Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type.

Catherine Thieblemont1, Francesco Bertoni2, Christiane Copie-Bergman3, Andrés J M Ferreri4, Maurilio Ponzoni5.   

Abstract

Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT) is an indolent B-cell non-Hodgkin lymphoma (NHL) arising in lymphoid populations that are induced by chronic inflammation in extra nodal sites. The stomach is the most commonly affected organ, and MALT lymphoma is clearly associated with a gastroduodenitis induced by a microbial pathogen, Helicobacter pylori, thus gastric MALT lymphoma represents a paradigm for evaluating inflammatory-associated lymphomagenesis. Variable levels of evidence have indicated a possible association between other microorganisms and non-gastric MALT lymphomas. In addition to infectious etiology, chronic inflammation arising as a result of autoimmune diseases such as Sjogren's syndrome or Hashimoto thyroiditis, poses a significant risk factor for developing NHL. Recently, genetic alterations affecting the NF-κB pathway, a major signaling pathway involved in many cancers, have been identified in MALT lymphoma. This review will present MALT lymphoma as an example of the close pathogenetic link between chronic microenvironmental inflammation and tumor development, showing how these observations can be integrated into daily clinical practice, also in terms of therapeutic implications, with particular focus on the NF-κB pathway.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic inflammation; MALT lymphoma; Marginal zone; Microbial pathogen autoimmune disease

Mesh:

Substances:

Year:  2013        PMID: 24333758     DOI: 10.1016/j.semcancer.2013.11.005

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  20 in total

1.  G-protein coupled receptor (GPCR) mutations in lymphoid malignancies: linking immune signaling activation and genetic abnormalities.

Authors:  Jose Angel Martinez-Climent
Journal:  Haematologica       Date:  2018-08       Impact factor: 9.941

2.  Chemotherapy is an efficient treatment in primary CNS MALT lymphoma.

Authors:  Clément Desjardins; Delphine Larrieu-Ciron; Sylvain Choquet; Karima Mokhtari; Frédéric Charlotte; Lucia Nichelli; Bertrand Mathon; Guido Ahle; Magali Le Garff-Tavernier; Andrea Morales-Martinez; Caroline Dehais; Khê Hoang-Xuan; Caroline Houillier
Journal:  J Neurooncol       Date:  2022-06-20       Impact factor: 4.506

Review 3.  De-escalating therapy in gastric aggressive lymphoma.

Authors:  Rosanna Cuccurullo; Silvia Govi; Andrés J M Ferreri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 4.  Clinical aspects of malt lymphomas.

Authors:  Christina Kalpadakis; Gerassimos A Pangalis; Theodoros P Vassilakopoulos; Stavroula Kyriakaki; Xanthi Yiakoumis; Sotirios Sachanas; Maria Moschogiannis; Pantelis Tsirkinidis; Penelope Korkolopoulou; Helen A Papadaki; Maria K Angelopoulou
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

Review 5.  The Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role?

Authors:  Christina Arieta Kuksin; Lisa M Minter
Journal:  Front Oncol       Date:  2015-02-24       Impact factor: 6.244

6.  Primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and literature review.

Authors:  Shigeyuki Nagata; Norifumi Harimoto; Kiyoshi Kajiyama
Journal:  Surg Case Rep       Date:  2015-09-24

7.  Ureteral Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Chronic Inflammation, and Renal Artery Atherosclerosis.

Authors:  Hojung Lee; Jong Eun Joo; Young Ok Hong; Won Mi Lee; Eun Kyung Kim; Jeong Joo Woo; Soo Jung Gong; Jooryung Huh
Journal:  J Pathol Transl Med       Date:  2015-07-15

8.  B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.

Authors:  Øystein Fluge; Kristin Risa; Sigrid Lunde; Kine Alme; Ingrid Gurvin Rekeland; Dipak Sapkota; Einar Kleboe Kristoffersen; Kari Sørland; Ove Bruland; Olav Dahl; Olav Mella
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 9.  A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.

Authors:  Sebastian Rasch; Hana Algül
Journal:  Clin Exp Gastroenterol       Date:  2014-08-11

Review 10.  Concurrent gastric and pulmonary mucosa-associated lymphoid tissue lymphomas with pre-existing intrinsic chronic inflammation: a case report and a review of the literature.

Authors:  Soo-Yeon Oh; Na-Young Kim; Dong Hyun Oh; Soo Mee Bang; Yoon Jin Choi; Ju Yub Lee; Kyung Won Lee; Ho Il Yoon; Hee Chul Yang; Jin Ho Paik; Dong Ho Lee; Hyun Chae Jung
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.